Dosering 2 x daags 1 vegacaps tijdens of direct na een maaltijd innemen, tenzij anders geadviseerd
In the New England Journal of Medicine, Garvey and colleagues [5] report the results of the REDEFINE 1 trial, a 68-week, phase 3a double-blind, placebo-controlled and active-controlled trial evaluating the efficacy and safety of coadministered cagrilintide and semaglutide in adults with obesity [body mass index (BMI) 30 kg/m 2 ] or overweight (BMI 27 kg/m 2 ) with at least one weight-related comorbidity
USA 116 , 1140811417 (2019)
Ghezzo A, Visconti P, Abruzzo PM, Bolotta A, Ferreri C, Gobbi G, Malisardi G, Manfredini S et al (2013) Oxidative stress and erythrocyte membrane alterations in children with autism: correlation with clinical features